Gastric juice levels of Lactoferrin and Helicobacter pylori infection

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 6, 1997, Pages 530-534

  Nakao, K ^a   Imoto, I ^a   Gabazza, E C ^a   Yamauchi, K ^a   Yamazaki, N ^a   Taguchi, Y ^a   Shibata, T ^a   Takaji, S ^a   Ikemura, N ^a   Misaki, M ^a  

^a NONE

Author keywords

Gastric juice; Helicobacter pylori; Lactoferrin; NaHCO3 solution

Indexed keywords

LACTOFERRIN;

ARTICLE; CHRONIC GASTRITIS; CONTROLLED STUDY; GASTROSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DETERMINATION; STOMACH BIOPSY; STOMACH JUICE;

EID: 8544277276     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709025094     Document Type: Article

References (34)

1. Johanson B. Isolation of an iron-containing red protein from human milk. Acta Chem Scand 1960;14:510-2.
2. Arnold RR, Brewer M, Gauthier JJ. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun 1980;28:893-8.
3. Breton-Gorius J, Mason DY, Buriot D, Vilde JL, Griscelli C. Lactoferrin deficiency as a consequence of lack of specific granules in neutrophils from a patient with recurrent infections. Am J Pathol 1980;99:413-9.
4. Arnold RR, Cole MF, McGhee JR. A bactericidal effect for human lactoferrin. Science 1977;197:263-5.
5. Weinberg ED. Iron with holding: a defence against infection and neoplasia. Physiol Rev 1984;64:65-102.
6. Lönnerdal B, Iyer S. Lactoferrin: molecular structure and biological function. Annu Rev Nutr 1995;15:93-110.
7. Danjo Y, Lee M, Horimoto K, Hamamoto T. Ocular surface damage and tear lactoferrin in dry eye syndrome. Acta Ophthalmol 1994;72:433-7.
8. Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobactcr pylori-induced inflammation. Gastroenterology 1992;102:720-7.
9. Dixon MF. Helicobacter pylori and peptic ulceration: histopathological aspects. J Gastroenterol Hepatol 1991;6:125-30.
10. Parsonnet J, Freedman GD, Vandersteen DP, Chang VY, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
11. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa associated lymphoid tissue to Helicobacter pylori. Lancet 1993;342:571-4.
12. Crabtree JE, Wyatt JI, Trejdosiewcz LK, Peichl P, Nichols PH, Ramsay N, et al. Interleukin-8 expression in Helicobacter pylori infected, normal and neoplastic gastroduodenal mucosa. J Clin Pathol 1994;47:61-6.
13. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC. Campylobacter pyloridis-associated chronic active antral gastritis; a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988;94: 33-40.
14. Gossens H, Glupczynski Y, Burette A, Van den Borre C, Deprez C, Bodenmann J, et al. Evaluation of a commercially available complement fixation test for diagnosis of Helicobacter pylori infection and for follow-up after antimicrobial therapy. J Clin Microbiol 1992;30:3230-3.
15. Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991;6:209-22.
16. Tsuchihashi K, Imoto I, Shibata T, Takaji S, Ikemura N, Taguchi Y, et al. Usefulness of measuring intragastric ammonia levels as a screening method for diagnosis of Helicobacter pylori infection. Gastrenterol Endosc 1993;35:253-60.
17. Bezwoda WR, Baynes RD, Khan O, Mansoor N. Enzyme linked immunosorbent assay for lactoferrin plasma and tissue measurements. Clin Chim Acta 1985;151:61-9.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
19. Luqmani YA, Campbell TA, Bennett C, Coombes RC, Paterson IM. Express of lactoferrin in human stomach. Int J Cancer 1991;49:684-7.
20. Suzuki T, Nonaka M, Kiyosawa I, Ogasa K. Peptic digestion of human and bovine lactoferrin. J Jpn Soc Nutr Food Sci 1978; 31:395-403.
21. Brock JH, Arzabe F, Lampreave F, Pineiro A. The effect of trypsin on bovine transferrin and lactoferrin. Biochim Biophys Acta 1976;446:214-25.
22. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in chronic gastritis. Lancet 1983;1:1273-5.
23. Hazall SL, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucous as an important factors in colonization of the gastric epithelium. J Infect Dis 1986;153: 658-63.
24. Tsujii M, Kawano S, Tsuji S, Fusamoto H, Kamada T, Sato N. Mechanism of gastric mucosal damage induced by ammonia. Gastroenterology 1992;102:1881-8.
25. Cover TL, Cao P, Lind CD, Tham KT, Blaser MJ. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993;61: 5008-12.
26. Davies GR, Simmonds NJ, Stevens TRJ, Sheaff MT, Banatvala N, Laurenson IF, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994;35:179-85.
27. Marshall BJ. Virulence and pathogenicity of Helicobacter pylori. J Gastroenterol Hepatol 1992;6:121-4.
28. Husson MO, Legrand D, Spik G, Leclerc H. Iron acquisition by Helicobacter pylori: importance of human lactoferrin. Infect Immun 1993;61:2694-7.
29. Dial EJ, Serna JA, Lichtenberger LM. Lactoferrin inhibits the growth of Helicobacter pylori in vitro. Gastroenterology 1995; 108:A82.
30. Dial EJ, Hall LR, Lichtenberger LM. Antimicrobial properties of lactoferrin which limit Helicobacter pylori (HP) growth. Gastroenterology 1996;110:A95.
31. Miehlke S, Osato MS, Reddy R, Ward PP, Conneely OM, Graham DY. Direct antibacterial activity of recombinant human lactoferrin against Helicobacter pylori. Gastroenterology 1996; 110:A196.
32. Ellison RT, Giehl TJ, Laforce FM. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun 1988;61:719-28.
33. Yamauchi K, Tomita M, Giehl TJ, Ellison III RT. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 1993;61:719-28.
34. Ward PP, Piddington CS, Cunningham GA, Zhou X, Wyatt RD, Conneely OM. A system for production of commercial quantities of human lactoferrin, a broad spectrum natural antibiotic. Biotechnology 1995;13:498-503.